{"id":"W2786636081","doi":"10.1016/j.ophtha.2017.12.039","title":"Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III","year":2018,"lang":"en","type":"article","venue":"Ophthalmology","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"National Research Foundation of Korea; Ministry of Science, ICT and Future Planning; National Research Foundation","keywords":"Medicine; Adalimumab; Uveitis; Visual acuity; Interim analysis; Ophthalmology; Corticosteroid; Placebo; Intermediate uveitis; Adverse effect; Triamcinolone acetonide; Clinical trial; Surgery; Randomized controlled trial; Internal medicine; Anterior uveitis; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003303171,0.0007378032,0.001410283,0.0001922763,0.0004149124,0.001167325,0.0005546599,0.0008761144,0.002498645],"category_scores_gemma":[0.002182551,0.0002784265,0.001627296,0.0002665,0.0005967441,0.0006179744,0.0002770104,0.001670137,0.0004856143],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006531837,"about_ca_system_score_gemma":0.001297629,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004550447,"about_ca_topic_score_gemma":0.001144708,"domain_scores_codex":[0.9989083,0.0005880109,0.00009388886,0.0001476555,0.0001364769,0.0001257606],"domain_scores_gemma":[0.9979176,0.0004046386,0.0007560719,0.0002134463,0.0001469706,0.0005613294],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8579853,0.0213841,0.02497589,0.001352018,0.001665513,0.0001895139,0.0002798425,0.0004393407,0.0138507,0.0001400692,0.001483197,0.07625446],"study_design_scores_gemma":[0.4935572,0.4259537,0.07055683,0.0001889277,0.001117014,0.0004292511,0.0001103666,0.001035974,0.00372581,0.0002094648,0.00307487,0.00004046561],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918936,0.004186127,0.0005373685,0.0002222943,0.00007298908,0.001149889,0.0005183461,0.00005369317,0.001365676],"genre_scores_gemma":[0.9960338,0.0007486777,0.0007374626,0.0003808884,0.0001661259,0.0008469868,0.0005266769,0.00001012073,0.0005491458],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003303171,"threshold_uncertainty_score":0.01746905,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01989932771139518,"score_gpt":0.3385007757985986,"score_spread":0.3186014480872034,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}